Paramount Peptides score history
Every recorded change to Paramount Peptides’s overall score since October 8, 2026, with the audit note written at the time. Scores follow our published methodology; affiliate status never affects them.
- Score today
- 7.12/10
Score today
- Score changes
- 14
Score changes
- Audit entries
- 14
Audit entries
Score over time
Every entry newest first
- Lowered from7.13to7.12(-0.01)
Market medians updated on 3 November 2026 after the NextGen Peps re-check added priced listings: pricing 5.4 to 5.3.
- Lowered from7.15to7.13(-0.02)
Pricing recomputed on 26 October 2026: listings added for a newly reviewed vendor (Lotus Peptide) moved the market median for the same products: pricing 5.5 to 5.4.
- Lowered from7.16to7.15(-0.01)
Pricing recomputed on 25 October 2026: listings added for a newly reviewed vendor (Pexo Labs) moved the market median for the same products: pricing 5.6 to 5.5.
- Lowered from7.18to7.16(-0.02)
Pricing recomputed on 24 October 2026 after Bionova Peptides' first-review prices were recorded; other vendors move only through the market medians: pricing 5.7 to 5.6.
- Raised from7.16to7.18(+0.02)
Pricing recomputed on 24 October 2026: listings added for newly reviewed vendors moved the market median for the same products: pricing 5.6 to 5.7.
- Lowered from7.19to7.16(-0.03)
Pricing recomputed on 23 October 2026 from current listings with the published rule (section E), after listings added or updated since 22 October, including a newly reviewed vendor's, moved the market median for the same products: pricing 5.8 to 5.6.
- Raised from7.14to7.19(+0.05)
Lab score recalculated on 22 October 2026 under the published core-product rule (A1b): a missing certificate on one of the 15 most widely carried products still counts fully, while on any other product it now counts at half weight, so a broad catalogue is not penalised as much for its breadth. Lab 8.3 to 8.4.
- Raised from7.11to7.14(+0.03)
Operating history re-checked on 22 October 2026 under the published rule (earliest dated evidence of the business, including a never-parked store domain and the named operating company, looked up for every vendor): operating history 3.4 to 4.0.
- Raised from6.91to7.11(+0.20)
Re-scored on 22 October 2026 under the published rulebook, which now gives one rule for each judgement call and applies it to every vendor: shipping and refunds 5.5 to 6.5.
- Lowered from7.86to6.91(-0.95)
Re-scored on 22 October 2026 under our published rubric for shipping, pricing, operating history and transparency, applied to every vendor the same day: prices re-read from the vendor's site and matched by milligrams per vial, operating history from the earliest dated evidence of the business, and policies scored item by item. shipping and refunds 7.9 to 5.5, pricing 7.9 to 5.8, operating history 3.3 to 3.4, transparency 7.2 to 4.0.
- Raised from7.47to7.86(+0.39)
Janoshik certificates confirmed on 22 October 2026 at the laboratory's own verification site, so each confirmed report now earns the key-confirmed credit under our published lab rule. Lab 7.6 to 8.3.
- Raised from5.16to7.47(+2.31)
Lab evidence re-checked on 20 October 2026 under our coverage rule, which counts a listed product with no published certificate as zero in the lab average. Certificates cover 27 of the 28 products we list that the vendor offers for sale. Lab 3.4 to 7.6.
- Lowered from6.04to5.16(-0.88)
Lab 5.0 to 3.4. Recomputed under our published rule, which averages the lab score over the products we list and counts a listed product with no certificate as zero. The certificates in our archive have not been confirmed with the issuing laboratory, all are more than 12 months old, several listed products have no certificate, and the BPC-157 certificate reports BPC-157 as not detected. The 8 October 2026 entry described the archived certificates as verified; they are Janoshik-format reports in the vendor's name that we could not check with Janoshik.
- Raised from3.29to6.04(+2.75)
The lab score of zero was structural, set when certificates sat behind an email and passcode wall. That wall is gone and the lookup now takes a lot number. Certificates verified from our own archive are genuine Janoshik reports naming Paramount as client and manufacturer. Held at 5.0 because the documents are from June 2025, a certificate cannot be seen before purchase, no lab is named publicly, and the panel has no endotoxin, sterility or heavy metals. Separately recorded: their BPC-157 certificate reports BPC-157 not detected and acetylated BPC-157 in its place.
Score changes for every vendor are on the score changes page. Paramount Peptides may display its current score with the score badge, which updates automatically and has no effect on the score.